or Try an Advanced Search...

    Nervous System Disorders Stocks List

    Symbol Grade Name % Change
    AXSM B Axsome Therapeutics, Inc. 1.42
    MNOV B MediciNova, Inc. -3.36
    PRAX C Praxis Precision Medicines, Inc. -3.35
    BEAM D Beam Therapeutics Inc. -8.18
    PASG D Passage Bio, Inc. -11.88
    VNDA D Vanda Pharmaceuticals Inc. -2.58
    PRTC D PureTech Health plc -2.23
    ACAD D ACADIA Pharmaceuticals Inc. -1.87
    IRWD F Ironwood Pharmaceuticals, Inc. -2.21
    SAGE F Sage Therapeutics, Inc. -3.28
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Central Nervous System Disorders Biopharmaceutical Clinical Development Alzheimer's Disease Depression Medication Medicine Schizophrenia Antidepressants Biotechnology Chemical Compounds Chronic Pain Depressive Disorder Gastrointestinal Insomnia Major Depressive Disorder Organ Systems Pain Parkinson's Disease Psychosis

    Related ETFs - A few ETFs which own one or more of the above listed Nervous System Disorders stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 6.71
    PSIL C AdvisorShares Psychedelics ETF 5.67
    BBP B BioShares Biotechnology Products Fund 5.07
    ARKG C ARK Genomic Revolution Multi-Sector ETF 3.98
    XPH C SPDR S&P Pharmaceuticals ETF 3.62
    View all Nervous System Disorders ETFs...
    Compare ETFs
    Compare BBP to XPH Compare IBRN to PSIL Compare PSIL to XPH

        Nervous System Disorders Stocks Recent News

        Date Stock Title
        Dec 3 ACAD Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term
        Dec 3 PRAX Praxis Precision Medicines to Present at Upcoming December Investor Conferences
        Nov 30 PASG Passage Bio assumed with an Outperform at Wedbush
        Nov 29 AXSM Axsome: Focus On AXS-12 Targeting Narcolepsy, Which Just Released Positive Data
        Nov 29 PASG Update: Wedbush Raises Price Target on Passage Bio to $4 From $3, Keeps Outperform Rating
        Nov 27 ACAD Acadia: Scope Of Company Goes Beyond Recent SAN711 Licensing Deal For ET
        Nov 27 AXSM Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
        Nov 27 AXSM Axsome Therapeutics' AXS-12 Data For Sleeping Disorder Boosts Confidence In Approval And Market Potential, Analyst Says
        Nov 27 ACAD ACAD Signs License Deal With Saniona for Rights to Neurology Drug
        Nov 27 ACAD Acadia signs agreement with Saniona to commercialise SAN711
        Nov 27 BEAM Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Central Nervous System Disorders Biopharmaceutical Clinical Development Alzheimer's Disease Depression Medication Medicine Schizophrenia Antidepressants Biotechnology Chemical Compounds Chronic Pain Depressive Disorder Gastrointestinal Insomnia Major Depressive Disorder Organ Systems Pain Parkinson's Disease Psychosis
        Nervous System Disorders

        Nervous system disorders are conditions that affect the functioning of the brain, spinal cord, and nerves. These disorders can affect the way the body moves, senses, thinks, and behaves. Examples of nervous system disorders include Alzheimer's disease, epilepsy, Parkinson's disease, multiple sclerosis, stroke, and spinal cord injuries.

        Browse All Tags